BACKGROUND INFORMATION ON THE PROCEDURE 
1. 
Submission of the dossier 
The  company  Boehringer  Ingelheim  International  GmbH  submitted  on  1  September  1999  an 
application  for  Marketing  Authorisation  to  the  European  Agency  for  the  Evaluation  of  Medicinal 
Products (EMEA) for Metalyse, in accordance with the centralised procedure falling within the scope 
of Part A of the Annex to Council Regulation No (EEC) 2309/93 of 22 July 1993. 
The Rapporteur and Co-Rapporteur appointed by the CPMP were: 
Rapporteur: 
Prof.  Bass 
Co-Rapporteur:    Prof. Garattini 
Licensing status: 
A new drug application was filed in USA in July 1999. 
The product was not licensed in any country at the time of submission of the application. 
2. 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Steps taken for the assessment of the product 
The procedure started on 24 September 1999. 
The  Rapporteur's  first  assessment  report  was  circulated  to  all  CPMP  Members  on                           
3  December  1999.  The  Co-Rapporteur's  first  assessment  report  was  circulated  to  all  CPMP 
Members on 2 December 1999. 
During the meeting on 19 January 2000 the CPMP agreed on the consolidated list of questions 
to be sent to the company. The final consolidated list of questions was sent to the company on –
20 January 2000. 
The  company  submitted  the  responses  to  the  CPMP  consolidated  list  of  questions  on                     
3 July 2000.  
The  summary  report  of  the  inspection  carried  out  at  the  manufacturing  site  between                          
14-19 April 2000 of the Abbott Laboratories, Rocky Mount, USA was issued on 7 June  
The  Rapporteur  Co-Rapporteur  circulated  the  response  assessment  report  on  the  company’s 
responses to the list of questions to all CPMP Members on 28 August 2000.  
During the meeting on 21 September 2000 the CPMP agreed on the list of outstanding issues  to 
be  sent  to  the  company.  The  final  consolidated  list  of  outstanding  issues  was  sent  to  the 
company on. 21 September 2000. 
The  Joint  Rapporteur/Co-Rapporteur  Assessment  Report  on  the  responses  provided  by  the 
applicant was circulated to the CPMP on dated 9 and 12 October 2000. 
During  the  CPMP  meeting on  18 October outstanding issues that  had  previously addressed  in 
writing by the applicant were discussed.  
During the meeting on 18 October the CPMP, in the light of the overall data submitted and the 
scientific discussion within the Committee, issued a positive opinion for granting a Marketing 
Authorisation to Metalyse on 18 October 2000. 
1/1 
EMEA 2005 
 
 
 
 
 
 
 
 
